Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Ceramides Drive RGNNV Replication via Autophagy
2026-08-15
Zhang and colleagues used global lipidomics and targeted functional experiments to show that red-spotted grouper nervous necrosis virus reshapes host ceramide metabolism and uses ceramide accumulation to support replication. The work connects capsid-protein activity, sphingolipid pathways, and autophagy, providing a mechanistic framework for studying antiviral intervention in aquaculture rather than treating lipid changes as passive infection markers.
-
Anti-Inflammatory Airway Stent Limits Tracheal Restenosis
2026-08-14
Zhao and colleagues developed PAGL, an electrospun airway stent combining anlotinib hydrochloride with silver nanoparticles to address inflammation, infection, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. The study supports a multifunctional stent strategy, while its rabbit and transcriptomic data also identify important questions for clinical translation.
-
A-1210477 Workflow for MCL-1 Apoptosis
2026-08-14
A-1210477 is a selective MCL-1 inhibitor for resolving whether cancer-cell survival depends on the MCL-1–BIM axis and mitochondrial apoptosis. This practical workflow covers stock handling, dose-response design, combination testing, assay selection, and troubleshooting for reproducible in vitro cancer research.
-
Fludarabine in Hematologic Assays: A Sequencing Lens
2026-08-13
Fludarabine is a DNA synthesis inhibitor with value beyond a single cytotoxicity endpoint. This guide connects its F-ara-ATP mechanism with genotype-aware assay design, helping leukemia research and multiple myeloma research teams distinguish replication stress, cell-cycle arrest, and apoptosis.
-
Epoxomicin and ER Stress: Translational Proteasome Logic
2026-08-13
Epoxomicin is a selective, irreversible proteasome inhibitor that can help translational researchers connect protein degradation, ER stress, and disease-model phenotypes. This thought-leadership guide integrates the UBR1/UBR2 ER-stress findings with practical assay design, competitive positioning, and responsible translational interpretation.
-
Hoechst 33342/PI Double Staining Kit for RCC
2026-08-12
Apply dual nuclear and membrane-integrity fluorescence to distinguish viable, apoptotic, and necrotic renal cell carcinoma cells after esculin treatment. This practical workflow shows how to pair the Hoechst 33342/PI Double Staining Kit with viability, proliferation, migration, and protein assays for stronger mechanistic conclusions.
-
GW4064 in FXR Signaling and Fibrosis Research
2026-08-12
GW4064 is a selective, non-steroidal FXR agonist for separating receptor-driven signaling from nanoparticle-induced stress in cell and metabolic models. This practical guide explains how to build dose-response, fibrosis, lipid-regulation, and pathway-validation workflows while managing solubility, light sensitivity, and vehicle effects.
-
Cy5 amine (non-sulfonated): Labeling Guide
2026-08-11
Cy5 amine (non-sulfonated) provides a primary amino group for covalent attachment to activated biomolecules while delivering red fluorescence near 662 nm. Its water-insoluble profile requires preparation in DMSO or ethanol before transfer into an appropriate aqueous labeling workflow, and it is not intended for diagnostic or medical use.
-
D-N-Acetylgalactosamine: Workflow Guide
2026-08-11
D-N-Acetylgalactosamine provides a high-purity, water-soluble reagent for glycoprotein composition, glycosylation pathway, and brain heteropolysaccharides analysis. It is suitable for aqueous or DMSO-based workflows, but not for ethanol-based preparation or long-term storage of working solutions.
-
Exemestane: Steroidal Aromatase Inhibitor Guide
2026-08-10
Exemestane is a steroidal aromatase inhibitor that produces mechanism-based, irreversible inhibition of CYP19A1 and reduces estrogen biosynthesis. Its defined biochemical potency, steroidal structure, and product-specific handling profile support controlled use in breast cancer research and hormone-biology assays.
-
Fosinopril sodium Workflows for ACE Research
2026-08-09
Build prodrug-aware ACE inhibition assays, hypertension research workflows, and cardiovascular disease models around Fosinopril sodium. This guide pairs practical formulation and exposure controls with catalpol-informed cardiac, vascular, and renal endpoints for more interpretable translational data.
-
4-MUG: A Functional Readout of Lysosomal GCase
2026-08-08
4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) converts glycosidase activity into a measurable fluorescent signal. This guide explains how to interpret that signal in lysosomal biology, Gaucher disease models, and translational enzyme-restoration studies.
-
Fractional Killing by High-Throughput Microscopy
2026-08-07
The reference protocol establishes a time-resolved, high-throughput microscopy workflow for measuring the fraction of cells killed by anticancer treatments rather than relying only on population-level endpoint viability. Its use of fluorescent live-cell labeling, dead-cell detection, and parallel imaging provides a practical framework for comparing heterogeneous responses to mitogen-activated protein kinase pathway inhibitors.
-
α-Amanitin for Transcriptional Regulation: Advanced Protocol
2026-08-07
α-Amanitin enables precise, selective inhibition of RNA polymerase II, empowering researchers to dissect gene expression pathways at single-cell and developmental scales. This guide delivers stepwise workflows, troubleshooting strategies, and practical interpretations of breakthrough findings in oocyte chromatin reorganization and transcriptional regulation research.
-
IGF2BP1-THBS1 Axis Regulates Macrophage Metabolism in Lung F
2026-08-06
The referenced study uncovers how the m6A reader IGF2BP1 drives pulmonary fibrosis by stabilizing THBS1 mRNA, promoting macrophage M2 polarization and glycolytic activation through a TLR4-dependent pathway. These insights establish a mechanistic axis with potential implications for targeted intervention in fibrotic lung disease models.